Advertisements


We are Sorry, This Page doesn't Exist


Idera Stock Down, Study on Dermatomyositis Candidate Fails

Shares of Idera (IDRA) decline following the failure of a phase II study of its pipeline candidate, IMO-8400, on adult patients with dermatomyositis. Idera Pharmaceuticals Inc IDRA announced that the phase II clinical study, eva.....»»

Category: smallbizSource: nytJun 13th, 2018

CTI BioPharma Tanks Post Type B Talks on Pacritinib With FDA

CTI BioPharma (CTIC) conducts Type B meeting with the FDA to discuss a regulatory pathway for its lead pipeline candidate Pacritinib, currently under study for the treatment of myelofibrosis. Shares of CTI BioPharma Corp. CTIC plung.....»»

Category: worldSource: nytJul 19th, 2018

A Single Study Is No Reason to Sell Crispr Stock

Investo.....»»

Category: topSource: investorplaceJul 17th, 2018

Zogenix"s Epilepsy Candidate Successful in Phase III Study

Zogenix's (ZGNX) shares rally after successful completion of confirmatory phase III study of ZX008 for treating Dravet syndrome. Zogenix, Inc. ZGNX announced successful completion of its s.....»»

Category: worldSource: nytJul 13th, 2018

Bankrate Study: 10 Worst States to Retire List for 2018

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bankrate has delivered once again with its 2018 list of the best and worst states to retire, a selection that looks at a multitude of factors when deciding the best and.....»»

Category: topSource: investorplaceJul 12th, 2018

Bankrate Study: 10 Best States to Retire List for 2018

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bankrate .....»»

Category: topSource: investorplaceJul 12th, 2018

NewsWatch: The stock market’s next step could be its most pivotal

The U.S. stock market’s bulls and bears have for months been a arm-wrestling match with no end in sight. However, whichever side “wins” could dictate the tone on Wall Street for months......»»

Category: topSource: marketwatchJul 12th, 2018

Xencor doses first patient in Phase 1 study of solid tumors candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

OncoCyte (OCX) Stock Skyrockets on Lung Cancer Test Study Results

InvestorPlace - Stock Market News, Stock Advice & Tradi.....»»

Category: topSource: investorplaceJul 10th, 2018

Advaxis initiates IND with FDA to study first ADXS-HOT drug candidate for NSCLC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Lockheed Martin Stock Is a Case Study for Buying on the Dip

InvestorPlace - Sto.....»»

Category: topSource: investorplaceJul 9th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Biogen"s Alzheimer Disease Candidate Succeeds in Phase II

Biogen's (BIIB) Alzheimer's disease (AD) candidate demonstrates statistically significant slowdown in disease progression and reduction of amyloid beta accumulation in t.....»»

Category: smallbizSource: nytJul 6th, 2018

Biogen"s stock soars after positive results from study of Alzheimer"s treatment

Shares of Biogen Inc. soared 12% toward a five-month high in premarket trade Friday, after the biotechnology company and Tokyo-based Eisai Co. Ltd. announced positive results from a.....»»

Category: topSource: marketwatchJul 6th, 2018

HC Wainwright Unfazed By Zynerba Ending ZYN001: Drug "Wasn"t In Our Numbers"

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) stock plummeted 17.8 percent at Thursday’s open after the company ended a Phase 1 study for ZYN001, a tetrahydrocannabi Latest Ratin.....»»

Category: blogSource: benzingaJul 5th, 2018

Cytori reports improved skin healing in pivotal burn preclinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

uniQure enrolls first patient in Phase III HOPE-B pivotal study of AMT-061

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Global Blood Therapeutics Meets Primary Endpoints In Sickle Cell Study, Seeks Accelerated FDA Approval

Global Blood Therapeutics Inc (NASDAQ: GBT) shares were trading down off the open Wednesday after the company released data from its sickle cell disease candidate. read more.....»»

Category: blogSource: benzingaJun 27th, 2018

Kroger"s Stock Met Its Value Potential; Pivotal Downgrades To Hold

Kroger Co (NYSE: KR) spiked last week on a significant earnings beat and drove the stock just shy of one analyst’s optimal valuation. La.....»»

Category: blogSource: benzingaJun 25th, 2018

Market Extra: This one factor has determined which stocks rise or fall on trade-war fears

In a volatile year for the U.S. equity market, one factor has emerged as pivotal in determining whether a stock is likely to rise amid growing concerns over trade policy: how much the U.S. company focuses on the U.S......»»

Category: topSource: marketwatchJun 23rd, 2018